Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Natural Killer Cell Subsets in Cerebrospinal Fluid of Patients with Multiple Sclerosis.
Safety, Tolerability, and Efficacy of Oral Therapies for Relapsing-Remitting Multiple Sclerosis.
The secretome of mesenchymal stem cells: Potential implications for neuroregeneration.
Improving multiple sclerosis care: an analysis of the necessity for medication therapy management services among the patient population.
Ubiquitous Over-Expression of Chromatin Remodeling Factor SRG3 Ameliorates the T Cell-Mediated Exacerbation of EAE by Modulating the Phenotypes of both Dendritic Cells and Macrophages.
Effects of long-term whole-body vibration training on mobility in patients with multiple sclerosis: A meta-analysis of randomized controlled trials.
Multiple sclerosis: Scoring system to predict response to IFN-β in patients with multiple sclerosis.
Disease Activity Free Status: A New End Point for a New Era in Multiple Sclerosis Clinical Research?
Immune-regulatory mechanisms of classical and experimental multiple sclerosis drugs: special focus on helminth-derived treatments.
Multi-channel registration of fractional anisotropy and T1-weighted images in the presence of atrophy: application to multiple sclerosis.
Defining a role for laquinimod in multiple sclerosis.
Single Dose of Glycoengineered Anti-CD19 Antibody (MEDI551) Disrupts Experimental Autoimmune Encephalomyelitis by Inhibiting Pathogenic Adaptive Immune Responses in the Bone Marrow and Spinal Cord While Preserving Peripheral Regulatory Mechanisms.
Early-onset of multiple sclerosis in a 5-year-old girl.
Chronic cerebrospinal venous insufficiency is not associated with multiple sclerosis and its severity: a blind-verified study.
Partnering to Increase Access to Community Exercise Programs for People With Stroke, Acquired Brain Injury and Multiple Sclerosis.
The role of neurotrophins in multiple sclerosis-pathological and clinical implications.
Role of Rho Kinase and Fasudil on Synaptic Plasticity in Multiple Sclerosis.
Role of puberty in multiple sclerosis risk and course.
Effect of seasonal fluctuation of ambient temperature on fatigue in multiple sclerosis patients living in Attica, Greece.
Data collection capabilities of a new non-invasive monitoring system for patients with advanced multiple sclerosis.
Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis.
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.
Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients.
Effect of Inhaled Interferon Beta-1a on Carbon Monoxide Transfer Factor in Healthy Volunteers.
Posterior Reversible Encephalopathy Syndrome due to High Dose Corticosteroids for an MS Relapse.
Pages
« first
‹ previous
…
460
461
462
463
464
465
466
467
468
…
next ›
last »